Anebulo Pharmaceuticals Cash Flow Statement 2020-2024 | ANEB

Fifteen years of historical annual cash flow statements for Anebulo Pharmaceuticals (ANEB).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-8.20$-11.73$-6.83$-30.25$-0.17
$0.15$0$0$0$0
$0.76$0.88$0.48$26.83$0.00
$0.91$0.88$0.48$26.83$0.00
$0$0$0$0.00$0
$0$0$0$0$0
$-0.38$0.15$0.27$0.11$0
$0.01$0.61$0.64$-1.67$0
$-0.80$1.16$0.91$-1.45$0.02
$-8.09$-9.68$-5.44$-4.87$-0.15
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$-0.20$0
$0$0$0$0$0.20
$0$0$0$-0.20$0.20
$0$6.70$0$20.60$0
$0$6.70$0$20.60$3.00
$0$0$0$0$0
$-0.06$-0.32$0$1.43$-0.02
$-0.06$6.38$0$21.83$3.18
$-8.15$-3.30$-5.44$16.96$3.03
$0.76$0.88$0.48$0.20$0
$0$0$0$0$0